Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2

被引：27
作者：
Shahrajabian, Mohamad Hesam [1 ]
Sun, Wenli [1 ]
Cheng, Qi [1 ,2 ,3 ]
机构：
[1] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing, Peoples R China
[2] Hebei Agr Univ, Coll Life Sci, Baoding, Hebei, Peoples R China
[3] Global Alliance HeBAU CLS & HeQiS BioAl Mfg, Baoding, Hebei, Peoples R China
来源：
HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2021年 / 17卷 / 01期
关键词：
SARS; coronaviruses; SARS-CoV-2; MERS; pneumonia; emerging diseases; RESPIRATORY SYNDROME-CORONAVIRUS; RECEPTOR-BINDING DOMAIN; DIPEPTIDYL PEPTIDASE 4; ELICITS HIGH TITERS; SPIKE PROTEIN; 2019; COVID-19; IN-VITRO; IMMUNE-RESPONSES; SAUDI-ARABIA; FUNCTIONAL-CHARACTERIZATION;
D O I：
10.1080/21645515.2020.1797369
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
SARS-CoV-2, the virus causing COVID-19, is a single-stranded RNA virus belonging to the order Nidovirales, family Coronaviridae, and subfamily Coronavirinae. SARS-CoV-2 entry to cellsis initiated by the binding of the viral spike protein (S) to its cellular receptor. The roles of S protein in receptor binding and membrane fusion makes it a prominent target for vaccine development. SARS-CoV-2 genome sequence analysis has shown that this virus belongs to the beta-coronavirus genus, which includes Bat SARS-like coronavirus, SARS-CoV and MERS-CoV. A vaccine should induce a balanced immune response to elicit protective immunity. In this review, we compare and contrast these three important CoV diseases and how they inform on vaccine development.
引用
收藏
页码：62 / 83
页数：22
相关论文
共 348 条
[1]   Epidemiology, genome, and clinical features of the pandemic SARS-CoV-2: a recent view [J].
Abduljalil, J. M. ;
Abduljalil, B. M. .
NEW MICROBES AND NEW INFECTIONS, 2020, 35
[2]   Ratification vote on taxonomic proposals to the International Committee on Taxonomy of Viruses (2012) [J].
Adams, M. J. ;
Carstens, E. B. .
ARCHIVES OF VIROLOGY, 2012, 157 (07) :1411-1422
[3]   Individual and network characteristic associated with hospital-acquired Middle East Respiratory Syndrome coronavirus [J].
Adegboye, Oyelola ;
Saffary, Timor ;
Adegboye, Majeed ;
Elfaki, Faiz .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (03) :343-349
[4]   Small-Molecule Antiviral β-D-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance [J].
Agostini, Maria L. ;
Pruijssers, Andrea J. ;
Chappell, James D. ;
Gribble, Jennifer ;
Lu, Xiaotao ;
Andres, Erica L. ;
Bluemling, Gregory R. ;
Lockwood, Mark A. ;
Sheahan, Timothy P. ;
Sims, Amy C. ;
Natchus, Michael G. ;
Saindane, Manohar ;
Kolykhalov, Alexander A. ;
Painter, George R. ;
Baric, Ralph S. ;
Denison, Mark R. .
JOURNAL OF VIROLOGY, 2019, 93 (24)
[5]   Controlling SARS: a review on China's response compared with other SARS-affected countries [J].
Ahmad, Amena ;
Krumkamp, Ralf ;
Reintjes, Ralf .
TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2009, 14 :36-45
[6]   The risk factors associated with MERS-CoV patient fatality: A global survey [J].
Ahmadzadeh, Jamal ;
Mobaraki, Kazhal ;
Mousavi, Seyed Jalil ;
Aghazadeh-Attari, Javad ;
Mirza-Aghazadeh-Attari, Mohammad ;
Mohebbi, Iraj .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 96 (03)
[7]   Diagnostic delays in Middle East respiratory syndrome coronavirus patients and health systems [J].
Ahmed, Anwar E. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (06) :767-771
[8]   Diagnostic delays in 537 symptomatic cases of Middle East respiratory syndrome coronavirus infection in Saudi Arabia [J].
Ahmed, Anwar E. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 :47-51
[9]   Dual effect of nitric oxide on SARS-CoV replication: Viral RNA production and palmitoylation of the S protein are affected [J].
Akerstrom, Sara ;
Gunalan, Vithiagaran ;
Keng, Choong Tat ;
Tan, Yee-Joo ;
Mirazimi, Ali .
VIROLOGY, 2009, 395 (01) :1-9
[10]   Epidemiology and predictors of survival of MERS-CoV infections in Riyadh region, 2014-2015 [J].
Al-Jasser, Fahad S. ;
Nouh, Randa M. ;
Youssef, Randa M. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (02) :171-177
12345678910